GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vetoquinol SA (FRA:8JM) » Definitions » Institutional Ownership

Vetoquinol (FRA:8JM) Institutional Ownership : 15.15% (As of Jun. 17, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vetoquinol Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vetoquinol's institutional ownership is 15.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vetoquinol's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vetoquinol's Float Percentage Of Total Shares Outstanding is 0.00%.


Vetoquinol Institutional Ownership Historical Data

The historical data trend for Vetoquinol's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vetoquinol Institutional Ownership Chart

Vetoquinol Historical Data

The historical data trend for Vetoquinol can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 14.80 14.74 14.66 14.74 14.87 15.28 15.32 15.40 15.15 15.15

Vetoquinol Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Vetoquinol (FRA:8JM) Business Description

Traded in Other Exchanges
Address
Magny-Vernois, BP 189, Lure cedex, FRA, 70204
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.

Vetoquinol (FRA:8JM) Headlines

No Headlines